| 1 | had | 137,120 |
| 2 | -using | 7 |
| 3 | .statins | 2 |
| 4 | daiza | 2 |
| 5 | enos-derived | 2 |
| 6 | ii-the | 2 |
| 7 | 'playing | 1 |
| 8 | .whilst | 1 |
| 9 | 2-not | 1 |
| 10 | 3=bacteriostatic | 1 |
| 11 | 50/0 | 1 |
| 12 | components-the | 1 |
| 13 | discontinued/ | 1 |
| 14 | double-blinded.shock-only | 1 |
| 15 | efbs | 1 |
| 16 | follow-up-but | 1 |
| 17 | heat/acid-activated | 1 |
| 18 | hereterogeneity | 1 |
| 19 | histamine-stimulated | 1 |
| 20 | i-the | 1 |
| 21 | mnps-fe₃o₄was | 1 |
| 22 | participants.a | 1 |
| 23 | persistent/longstanding | 1 |
| 24 | resilience-yet | 1 |
| 25 | rongcheng | 1 |
| 26 | sextet | 1 |
| 27 | type-associated | 1 |
| 28 | uhr-c. | 1 |
| 29 | vowed | 1 |
| 30 | weeks.from | 1 |
| 31 | witho | 1 |
| 32 | woman-with | 1 |
| 33 | ₂and | 1 |
| 1 | 'playing | 1 |
| 2 | -using | 7 |
| 3 | .statins | 2 |
| 4 | .whilst | 1 |
| 5 | 2-not | 1 |
| 6 | 3=bacteriostatic | 1 |
| 7 | 50/0 | 1 |
| 8 | components-the | 1 |
| 9 | daiza | 2 |
| 10 | discontinued/ | 1 |
| 11 | double-blinded.shock-only | 1 |
| 12 | efbs | 1 |
| 13 | enos-derived | 2 |
| 14 | follow-up-but | 1 |
| 15 | had | 137,120 |
| 16 | heat/acid-activated | 1 |
| 17 | hereterogeneity | 1 |
| 18 | histamine-stimulated | 1 |
| 19 | i-the | 1 |
| 20 | ii-the | 2 |
| 21 | mnps-fe₃o₄was | 1 |
| 22 | participants.a | 1 |
| 23 | persistent/longstanding | 1 |
| 24 | resilience-yet | 1 |
| 25 | rongcheng | 1 |
| 26 | sextet | 1 |
| 27 | type-associated | 1 |
| 28 | uhr-c. | 1 |
| 29 | vowed | 1 |
| 30 | weeks.from | 1 |
| 31 | witho | 1 |
| 32 | woman-with | 1 |
| 33 | ₂and | 1 |
| 1 | uhr-c. | 1 |
| 2 | discontinued/ | 1 |
| 3 | 50/0 | 1 |
| 4 | participants.a | 1 |
| 5 | daiza | 2 |
| 6 | 3=bacteriostatic | 1 |
| 7 | had | 137,120 |
| 8 | type-associated | 1 |
| 9 | histamine-stimulated | 1 |
| 10 | heat/acid-activated | 1 |
| 11 | enos-derived | 2 |
| 12 | vowed | 1 |
| 13 | ₂and | 1 |
| 14 | i-the | 1 |
| 15 | ii-the | 2 |
| 16 | components-the | 1 |
| 17 | rongcheng | 1 |
| 18 | persistent/longstanding | 1 |
| 19 | -using | 7 |
| 20 | 'playing | 1 |
| 21 | woman-with | 1 |
| 22 | weeks.from | 1 |
| 23 | witho | 1 |
| 24 | mnps-fe₃o₄was | 1 |
| 25 | efbs | 1 |
| 26 | .statins | 2 |
| 27 | sextet | 1 |
| 28 | resilience-yet | 1 |
| 29 | 2-not | 1 |
| 30 | .whilst | 1 |
| 31 | follow-up-but | 1 |
| 32 | double-blinded.shock-only | 1 |
| 33 | hereterogeneity | 1 |